CN114053198A - 芦荟提取物 - Google Patents
芦荟提取物 Download PDFInfo
- Publication number
- CN114053198A CN114053198A CN202111568129.9A CN202111568129A CN114053198A CN 114053198 A CN114053198 A CN 114053198A CN 202111568129 A CN202111568129 A CN 202111568129A CN 114053198 A CN114053198 A CN 114053198A
- Authority
- CN
- China
- Prior art keywords
- aloe
- factory
- extract
- enzymolysis
- vera extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940069521 aloe extract Drugs 0.000 title claims abstract description 24
- 241001116389 Aloe Species 0.000 claims abstract description 79
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 79
- 238000000034 method Methods 0.000 claims abstract description 20
- 238000000605 extraction Methods 0.000 claims abstract description 14
- 230000008569 process Effects 0.000 claims abstract description 13
- 238000007789 sealing Methods 0.000 claims abstract description 10
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 9
- 238000003306 harvesting Methods 0.000 claims abstract description 6
- 238000003860 storage Methods 0.000 claims abstract description 5
- 239000000084 colloidal system Substances 0.000 claims abstract description 4
- 230000001954 sterilising effect Effects 0.000 claims description 19
- 238000004659 sterilization and disinfection Methods 0.000 claims description 17
- 239000000047 product Substances 0.000 claims description 15
- 235000014104 aloe vera supplement Nutrition 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 231100000241 scar Toxicity 0.000 claims description 6
- 150000004676 glycans Chemical class 0.000 claims description 5
- 229920001282 polysaccharide Polymers 0.000 claims description 5
- 239000005017 polysaccharide Substances 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 4
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 3
- 108010059892 Cellulase Proteins 0.000 claims description 3
- 108010059820 Polygalacturonase Proteins 0.000 claims description 3
- 206010039509 Scab Diseases 0.000 claims description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 3
- 229940106157 cellulase Drugs 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 3
- 238000005057 refrigeration Methods 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 3
- 239000008399 tap water Substances 0.000 claims description 3
- 235000020679 tap water Nutrition 0.000 claims description 3
- 239000002918 waste heat Substances 0.000 claims description 3
- 206010020880 Hypertrophy Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 20
- 239000013543 active substance Substances 0.000 abstract description 10
- 230000006870 function Effects 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 7
- 208000002874 Acne Vulgaris Diseases 0.000 description 6
- 206010000496 acne Diseases 0.000 description 6
- 230000003467 diminishing effect Effects 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 5
- AFHJQYHRLPMKHU-OSYMLPPYSA-N aloin A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-OSYMLPPYSA-N 0.000 description 5
- -1 anthraquinone compounds Chemical class 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 239000000843 powder Substances 0.000 description 4
- HKIKAXXIWJHWLY-ZIIYPAMZSA-N Aloesin Chemical compound C=12OC(CC(=O)C)=CC(=O)C2=C(C)C=C(O)C=1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HKIKAXXIWJHWLY-ZIIYPAMZSA-N 0.000 description 3
- HKIKAXXIWJHWLY-QEVGBQTESA-N Aloesin Natural products O=C(CC=1Oc2c([C@H]3[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O3)c(O)cc(C)c2C(=O)C=1)C HKIKAXXIWJHWLY-QEVGBQTESA-N 0.000 description 3
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000034189 Sclerosis Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 3
- 230000003780 keratinization Effects 0.000 description 3
- 201000004384 Alopecia Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- CPUHNROBVJNNPW-UHFFFAOYSA-N aloin A Natural products OC1C(O)C(O)C(CO)OC1OC1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 CPUHNROBVJNNPW-UHFFFAOYSA-N 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 201000010251 cutis laxa Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940006091 aloe polysaccharide Drugs 0.000 description 1
- KFJNVVJUICKJEQ-LQDZTQBFSA-N aloenin Chemical compound O1C(=O)C=C(OC)C=C1C1=C(C)C=C(O)C=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 KFJNVVJUICKJEQ-LQDZTQBFSA-N 0.000 description 1
- KFJNVVJUICKJEQ-UHFFFAOYSA-N aloenin Natural products O1C(=O)C=C(OC)C=C1C1=C(C)C=C(O)C=C1OC1C(O)C(O)C(O)C(CO)O1 KFJNVVJUICKJEQ-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229930182482 anthraquinone glycoside Natural products 0.000 description 1
- 229940098421 anthraquinone glycoside Drugs 0.000 description 1
- 150000008139 anthraquinone glycosides Chemical class 0.000 description 1
- 150000008425 anthrones Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Cardiology (AREA)
- Medical Informatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Alternative & Traditional Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Pulmonology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及芦荟提取技术领域,且公开了一种芦荟提取物,所述芦荟提取物的提取方式包括以下步骤:S1、在芦荟种植基地采摘收割成熟芦荟,完全洗净后用专用设备对芦荟进行高效去皮,再将去皮之后的芦荟果肉装桶密封后上车迅速运输至工厂;S2、运至工厂后,先用胶体磨机对芦荟进行磨汁后抽入储存罐,按专门配方与工艺进行酶解。该芦荟提取物,从基地芦荟收割后,直接运输到工厂萃取加工的时间严格控制在6小时内,同时我们将芦荟萃取成芦荟原汁,再加入优质保湿活性物,以此就可以达到低温、高效的目的,从而很好的保持芦荟活性物的活性,这样用我们萃取的芦荟提取物制成的芦荟胶等产品,就能起到很好的保湿修护等功效。
Description
技术领域
本发明涉及芦荟提取技术领域,具体为一种芦荟提取物。
背景技术
芦荟提取物,是一种无色透明至褐色的略带黏性的液体,干燥后为黄色精细粉末。没有气味或稍有特异气味。通常被用来做面膜,深受广大女性的喜爱。有很强的补水性能,现在市面上在售的芦荟胶,绝大部分是用芦荟干粉冲兑制作而成,而芦荟干粉的制作工艺流程如下:
鲜叶→清洗→消毒→粉碎→离心→100目过滤→浓缩至1:10浓缩液→称取一定重量浓缩液→冷冻→冻干。
芦荟本身含有丰富的活性物,现有的一些制作工艺中,芦荟干粉的提取技术耗时长,工艺复杂,将芦荟粉碎离心以及冷冻,会大大降低芦荟活性物的活性,使其制成产品的修护功能大打折扣。
发明内容
针对现有技术的不足,本发明提供了一种芦荟提取物,解决了将芦荟粉碎离心以及冷冻,会大大降低芦荟活性物的活性,使其制成产品的修护功能降低的问题。
为实现上述目的,本发明提供如下技术方案:一种芦荟提取物,所述芦荟提取物的提取方式包括以下步骤:
S1、在芦荟种植基地采摘收割成熟芦荟,完全洗净后用专用设备对芦荟进行高效去皮,再将去皮之后的芦荟果肉装桶密封后上车迅速运输至工厂。
S2、运至工厂后,先用胶体磨机对芦荟进行磨汁后抽入储存罐,按专门配方与工艺进行酶解。
S3、加热至80℃后通过振荡机过滤后,使用超临界萃取法对滤液进行提纯萃取,然后通过压滤机进行过滤,对过滤得到的原汁进行测固形物、多糖等指标,合格后通过蒸汽灭菌机高温灭菌后得到芦荟提取物。
S4、对获取的芦荟提取物进行装桶密封。
优选的,从基地芦荟收割后,直接运输到工厂萃取加工的时间严格控制在6小时内,同时我们不同于绝大多数厂家提取芦荟提取物的方法是,我们并不是将芦荟制作成干粉,而是将芦荟萃取成芦荟原汁,再加入优质保湿活性物,以此就可以达到低温、高效的目的,从而很好的保持芦荟活性物的活性,本产品的提取物中含有较多的活性成分,如叶含芦荟甙A、芦荟甙B、芦荟大黄素及芦荟糖甙A、B等,其主要成分为多糖类、蒽醌类化合物、蛋白质、维生素、矿物质等。
本提取物有较为广泛的用途,芦荟的蒽醌类化合物具有使皮肤收敛、柔软化、保湿、消炎、漂白的性能。还有解除硬化、角化、改善伤痕的作用,不仅能防止小皱纹、眼袋、皮肤松弛,还能保持皮肤湿润、娇嫩,同时,还可以治疗皮肤炎症,对粉刺、雀斑、痤疮以及烫伤、刀伤、虫咬等亦有很好的疗效。对头发也同样有效,能使头发保持湿润光滑,预防脱发。
优选的,所述步骤S2中酶解工艺条件是:果胶酶量9‰,纤维素酶量5‰,pH4.5,酶解温度45℃,所述酶解的时间3h。
优选的,所述步骤S3中高温灭菌的处理方式为现在60-65℃的状态下进行余热灭菌,然后经瞬时灭菌机进行高温灭菌,灭菌的温度为135℃,灭菌的时间为8-10s,灭菌完成之后冷却至常温。
优选的,在装桶密封时加入1.5%1,2-己二醇和1%1,3-丁二醇,通过加入这些物质,可以达到低温、高效的目的,从而很好的保持芦荟活性物的活性,这样用我们萃取的芦荟提取物制成的芦荟胶等产品,就能起到很好的保湿修护等功效。
优选的,待产品加工完成后,剔除煮烂的、干缩的、严重褐变的,成品按形状及色泽状况进行分袋和包装,包装之后将产品放置在冷库进行保藏,通过冷藏的方式,可以有效延长芦荟胶的额保存时间,使得加工之后的芦荟胶不易发生变质损坏。
优选的,在对芦荟进行加工时,选择肥大、无病斑和伤痕的芦荟叶片,在清洗的过程中取出鲜叶中腐烂、黄花部分,然后用流动的自来水清洗干净。有益效果如下:
该芦荟提取物,从基地芦荟收割后,直接运输到工厂萃取加工的时间严格控制在6小时内,同时我们将芦荟萃取成芦荟原汁,再加入优质保湿活性物,以此就可以达到低温、高效的目的,从而很好的保持芦荟活性物的活性,这样用我们萃取的芦荟提取物制成的芦荟胶等产品,就能起到很好的保湿修护等功效。
具体实施方式
基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
本发明提供一种技术方案:一种芦荟提取物,所述芦荟提取物的提取方式包括以下步骤:
S1、在芦荟种植基地采摘收割成熟芦荟,从基地芦荟收割后,直接运输到工厂萃取加工的时间严格控制在6小时内,完全洗净后用专用设备对芦荟进行高效去皮,再将去皮之后的芦荟果肉装桶密封后上车迅速运输至工厂,在对芦荟进行加工时选择肥大、无病斑和伤痕的芦荟叶片,在清洗的过程中取出鲜叶中腐烂、黄花部分,然后用流动的自来水清洗干净。
S2、运至工厂后,先用胶体磨机对芦荟进行磨汁后抽入储存罐,按专门配方与工艺进行酶解,酶解工艺条件是:果胶酶量9‰,纤维素酶量5‰,pH4.5,酶解温度45℃,所述酶解的时间3h。
S3、加热至80℃后通过振荡机过滤后,使用超临界萃取法对滤液进行提纯萃取,然后通过压滤机进行过滤,对过滤得到的原汁进行测固形物、多糖等指标,合格后通过蒸汽灭菌机高温灭菌后得到芦荟提取物,高温灭菌的处理方式为先在60-65℃的状态下进行余热灭菌,然后经瞬时灭菌机进行高温灭菌,灭菌的温度为135℃,灭菌的时间为8-10s,灭菌完成之后冷却至常温。
S4、对获取的芦荟提取物进行装桶密封,在装桶密封时加入1.5%1,2-己二醇和1%1,3-丁二醇,待产品加工完成后,剔除煮烂的、干缩的、严重褐变的,成品按形状及色泽状况进行分袋和包装,包装之后将产品放置在冷库进行保藏。
本产品的提取物中含有较多的活性成分,如叶含芦荟甙A、芦荟甙B、芦荟大黄素及芦荟糖甙A、B等,其主要成分为多糖类、蒽醌类化合物、蛋白质、维生素、矿物质等,同时本提取物有较为广泛的用途,芦荟的蒽醌类化合物具有使皮肤收敛、柔软化、保湿、消炎、漂白的性能。还有解除硬化、角化、改善伤痕的作用,不仅能防止小皱纹、眼袋、皮肤松弛,还能保持皮肤湿润、娇嫩,同时,还可以治疗皮肤炎症,对粉刺、雀斑、痤疮以及烫伤、刀伤、虫咬等亦有很好的疗效。对头发也同样有效,能使头发保持湿润光滑,预防脱发。
本提取物的功能主要有:杀菌和消炎功效、健胃和缓泻功效、抗癌功效、美容功效以及增强增强机体的免疫力。
(1)杀菌和消炎:芦荟中的蒽酮类化合物大多具有杀菌、抑菌、消炎、解毒、促进伤口愈合等作用,研究发现芦荟苦素和芦荟大黄素苷均具有杀菌、消炎作用,芦荟的杀菌、消炎功能能有效地消除粉刺、痤疮。
(2)健胃和缓泻:芦荟具有健胃和缓泻功效,主要是因为芦荟含有芦荟大黄素苷、芦荟宁、芦荟咪酊等有效成分.具有健胃和缓泻功能,起着增进食欲和大肠缓泻作用。芦荟大黄素苷是含蒽醌配糖体的衍生物。具有健胃作用,对多种便秘有明显的治疗作用。
(3)抗癌:芦荟醇提取物及芦荟苦素能明显提高机体免疫功能,芦荟是一种有希望的抗癌新药,临床应用芦荟治疗肝癌、胃癌、子宫癌等产生了意想不到的疗效。
(4)美容:芦荟含有的芦荟素、芦荟苦素,具有多方面美化皮肤的效能,在保湿、消炎、抑菌、止痒、抗过敏、软化皮肤、防粉刺、抑汗防臭等方面具有一定的作用,对紫外线有强烈的吸收作用,防止皮肤灼伤,使得芦荟具有使皮肤收敛、柔软化、保湿、消炎、解除硬化、角化、改善伤痕等作用。
(5)增强机体免疫力:研究结果表明,芦荟多糖对体内任何病巢都赋予抵抗能力,以提高自身力量来对抗病菌,加快治疗效果。芦荟中的芦荟素、多糖能强化心脏功能,促进血液循环,软化硬化的动脉,降低胆固醇值,扩张毛细血管,使血压正常化,对动脉硬化和高血压有一定的预防和治疗作用。
需要说明的是,在本文中,诸如第一和第二等之类的关系术语仅仅用来将一个实体或者操作与另一个实体或操作区分开来,而不一定要求或者暗示这些实体或操作之间存在任何这种实际的关系或者顺序。而且,术语“包括”、“包含”或者其任何其他变体意在涵盖非排他性的包含,从而使得包括一系列要素的过程、方法、物品或者设备不仅包括那些要素,而且还包括没有明确列出的其他要素,或者是还包括为这种过程、方法、物品或者设备所固有的要素。
尽管已经示出和描述了本发明的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由所附权利要求及其等同物限定。
Claims (7)
1.一种芦荟提取物,其特征在于:所述芦荟提取物的提取方式包括以下步骤:
S1、在芦荟种植基地采摘收割成熟芦荟,完全洗净后用专用设备对芦荟进行高效去皮,再将去皮之后的芦荟果肉装桶密封后上车迅速运输至工厂;
S2、运至工厂后,先用胶体磨机对芦荟进行磨汁后抽入储存罐,按专门配方与工艺进行酶解;
S3、加热至80℃后通过振荡机过滤后,使用超临界萃取法对滤液进行提纯萃取,然后通过压滤机进行过滤,对过滤得到的原汁进行测固形物、多糖等指标,合格后通过蒸汽灭菌机高温灭菌后得到芦荟提取物;
S4、对获取的芦荟提取物进行装桶密封。
2.根据权利要求1所述的芦荟提取物,其特征在于:从基地芦荟收割后,直接运输到工厂萃取加工的时间严格控制在6小时内。
3.根据权利要求1所述的芦荟提取物,其特征在于:所述步骤S2中酶解工艺条件是:果胶酶量9‰,纤维素酶量5‰,pH4.5,酶解温度45℃,所述酶解的时间3h。
4.根据权利要求1所述的芦荟提取物,其特征在于:所述步骤S3中高温灭菌的处理方式为先在60-65℃的状态下进行余热灭菌,然后经瞬时灭菌机进行高温灭菌,灭菌的温度为135℃,灭菌的时间为8-10s,灭菌完成之后冷却至常温。
5.根据权利要求1所述的芦荟提取物,其特征在于:在装桶密封时加入1.5%1,2-己二醇和1%1,3-丁二醇。
6.根据权利要求1所述的芦荟提取物,其特征在于:待产品加工完成后,剔除煮烂的、干缩的、严重褐变的,成品按形状及色泽状况进行分袋和包装,包装之后将产品放置在冷库进行保藏。
7.根据权利要求1所述的芦荟提取物,其特征在于:在对芦荟进行加工时选择肥大、无病斑和伤痕的芦荟叶片,在清洗的过程中取出鲜叶中腐烂、黄花部分,然后用流动的自来水清洗干净。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111568129.9A CN114053198A (zh) | 2021-12-21 | 2021-12-21 | 芦荟提取物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111568129.9A CN114053198A (zh) | 2021-12-21 | 2021-12-21 | 芦荟提取物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114053198A true CN114053198A (zh) | 2022-02-18 |
Family
ID=80230043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111568129.9A Pending CN114053198A (zh) | 2021-12-21 | 2021-12-21 | 芦荟提取物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114053198A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1419861A (zh) * | 2002-12-05 | 2003-05-28 | 苏州赛恩生物工程有限公司 | 芦荟凝胶汁降解澄清方法 |
CN107929184A (zh) * | 2017-11-29 | 2018-04-20 | 桂林华诺威生物科技有限公司 | 芦荟胶原蛋白保湿凝胶 |
JP2020083851A (ja) * | 2018-11-30 | 2020-06-04 | 森永乳業株式会社 | アロエ抽出物の製造方法 |
-
2021
- 2021-12-21 CN CN202111568129.9A patent/CN114053198A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1419861A (zh) * | 2002-12-05 | 2003-05-28 | 苏州赛恩生物工程有限公司 | 芦荟凝胶汁降解澄清方法 |
CN107929184A (zh) * | 2017-11-29 | 2018-04-20 | 桂林华诺威生物科技有限公司 | 芦荟胶原蛋白保湿凝胶 |
JP2020083851A (ja) * | 2018-11-30 | 2020-06-04 | 森永乳業株式会社 | アロエ抽出物の製造方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104825351B (zh) | 一种沉香美白洗面奶及其制备方法 | |
CN100401925C (zh) | 可有效预防和治疗哮喘的健康饮料的制造方法 | |
CN104686887A (zh) | 一种美容养颜蜂蜜膏及其制备方法 | |
CN103750328A (zh) | 一种冷冻干燥复方浆果超微粉及其生产方法 | |
CN104522456A (zh) | 一种海洋胶原蛋白蜂蜜膏及其制备方法 | |
CN103356442A (zh) | 一种以植物提取物为主要功能成分的防晒霜的生产方法 | |
CN103211051A (zh) | 一种桑提取物、生产方法及其用途 | |
CN107157835A (zh) | 一种预防或修复妊娠纹的复方精油及其制备方法 | |
CN110123694A (zh) | 一种不添加去离子水的抗敏修护化妆水及其制备方法 | |
CN104686888A (zh) | 一种具有改善皮肤功能的蜂蜜膏及其制备方法 | |
KR101978698B1 (ko) | 양파 추출물을 포함하는 피부관리 화장료 조성물 | |
JP3811198B2 (ja) | 米からの抗アレルギー剤 | |
CN106994148A (zh) | 一种祛痘中药制剂 | |
CN107439760A (zh) | 一种荷叶茶及其制备方法 | |
CN114053198A (zh) | 芦荟提取物 | |
CN104366356A (zh) | 一种甘薯深加工制备功能性营养品的方法 | |
KR102191929B1 (ko) | 코끼리마늘을 이용한 피부미용팩 조성물 및 그 제조방법 | |
CN108587828A (zh) | 一种白藜芦醇红酒的制备方法 | |
CN105558698A (zh) | 一种具有保健功能的芦荟饮料的制备方法 | |
KR20150062553A (ko) | 씀바귀 추출액을 함유하는 건강식품 조성물의 제조방법 및 이에 의해 제조된 씀바귀 추출액을 함유하는 건강식품 조성물 | |
CN105496885A (zh) | 一种含植物元素的化妆品及其生产方法 | |
JPH04169533A (ja) | 保健食品組成物の製造方法 | |
CN107412040B (zh) | 一种栀子面膜粉及其制备方法 | |
CN105326755B (zh) | 无添加剂绿豆祛痘养护面膜纸及其绿色生产方法 | |
CN1159923A (zh) | 芦荟浓缩胶原的提取方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220218 |